SCHEMBL17508491

SCHEMBL17508491

CCOC(=O)c1ccc(C2(N)CC2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.59
CYP1A2 P05177 2/20 0.59
CYP3A4 P08684 2/20 0.59
MAOA P21397 1/20 0.59
CA1 P00915 3/20 0.56
CA2 P00918 3/20 0.56
CA12 O43570 2/20 0.56
CA7 P43166 2/20 0.56
CA9 Q16790 2/20 0.56
CA14 Q9ULX7 2/20 0.56
ESR1 P03372 1/20 0.56
ESR2 Q92731 1/20 0.56
STS P08842 1/20 0.50
AKT1 P31749 1/20 0.49
AKT2 P31751 1/20 0.49
SMN1; SMN2 Q16637 4/20 0.49
NPSR1 Q6W5P4 4/20 0.49
GAA P10253 2/20 0.49
MAPK1 P28482 1/20 0.49
TSHR P16473 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17321361 0.90 AKT1 (0.55) LMNACYP1A2CYP3A4MAOACA1
SCHEMBL19331340 0.86 LMNA (0.54) LMNACYP1A2CYP3A4MAOACA1
SCHEMBL19331071 0.84 NPSR1 (0.50) LMNACYP1A2CYP3A4MAOACA1
SCHEMBL19343524 0.82 CYP1A2 (0.47) LMNACYP1A2CYP3A4MAOACA1
SCHEMBL871865 0.81 CA1 (0.52) CA1CA2CA12CA7CA9
SCHEMBL19331342 0.81 ATM (0.48) LMNACYP1A2CYP3A4MAOACA1
SCHEMBL87450 0.80 CA1 (0.83) LMNACYP1A2CYP3A4MAOACA1
Hydrochloric Acid SCHEMBL871688 0.79 CA1 (0.50) CA1CA2CA12CA7CA9
SCHEMBL6788089 0.78 CA1 (0.73) LMNACYP1A2CYP3A4MAOACA1
Cyclohexane SCHEMBL2917907 0.78 CA1 (0.73) LMNACYP1A2CYP3A4MAOACA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016021742-A1 HETEROCYCLIC COMPOUNDS AS EP4 RECEPTOR ANTAGONISTS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-02-11 WO disclosed
WO-2016021742-A1 HETEROCYCLIC COMPOUNDS AS EP4 RECEPTOR ANTAGONISTS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-02-11 WO disclosed